Walker, Paul Richard

 
Title Year Hits Downloads
Harnessing Microglia and Macrophages for the Treatment of Glioblastoma 2019 114 66
Targeting self- and neoepitopes with a modular self-adjuvanting cancer vaccine 2019 74 0
Peptides as cancer vaccines 2019 144 3
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients 2019 268 179
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models 2018 103 0
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines 2018 155 75
Let there be oxygen and T cells 2018 148 87
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma 2018 321 127
Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes 2017 299 3
ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells 2017 327 7
Immunothérapie des gliomes : illusion ou espoir ? 2017 170 0
Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? 2016 242 111
Cell-penetrating peptides-the Swiss Army knife of cancer vaccines 2016 377 179
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes 2016 287 114
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing 2016 314 484
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? 2016 237 135
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants 2016 369 103
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity 2015 339 4
The CD40/CD40L axis in glioma progression and therapy 2015 239 100
Immunotherapy of Brain Tumors 2015 274 0
Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells 2015 262 2
Immunotherapy for glioma: from illusion to realistic prospects? 2014 865 334
Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies 2013 345 0
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity 2013 365 224
Getting by with a little help from the right CD4+ T cells 2013 329 134
Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours 2013 421 220
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy 2012 390 620
Macrophages and Microglia in Brain Malignancies 2012 313 501
Oncology ESAB 2011 2011 380 8
Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development 2010 402 3
T-cell immunotherapy for malignant glioma: toward a combined approach 2010 412 2
Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes 2008 363 9
9648 3834